Tci Wealth Advisors, Inc. Intra Cellular Therapies, Inc. Transaction History

Tci Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$44.07 - $54.45 $2,511 - $3,103	57 Added 38.78%	204 $10,000
Q3 2022 Nov 08, 2022	SELL	$42.7 - $59.99 $1,024 - $1,439	-24 Reduced 14.04%	147 $7,000
Q2 2022 Jul 19, 2022	BUY	$43.0 - $65.64 $1,032 - $1,575	24 Added 16.33%	171 $10,000
Q1 2022 Apr 29, 2022	BUY	$38.74 - $62.09 $1,123 - $1,800	29 Added 24.58%	147 $9,000
Q3 2021 Oct 29, 2021	SELL	$28.72 - $42.49 $631 - $934	-22 Reduced 15.71%	118 $4,000
Q2 2021 Aug 02, 2021	BUY	$29.3 - $44.5 $1,230 - $1,869	42 Added 42.86%	140 $6,000
Q1 2021 Apr 29, 2021	BUY	$30.8 - $39.51 $3,018 - $3,871	98 New	98 $3,000

415

87.5M

284K

105K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12.4B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.